What happens when a medical device manufacturer spends months preparing to enter a new market, only to discover halfway through certification that it overlooked a critical regulatory requirement?
For some companies, the answer is repeating costly tests, delaying product launches, and scrambling to meet requirements they should have anticipated from the start.
And according to Dr. Yuan Li, this is an all-too-familiar problem in the medical device industry.
In this episode of The Global Marketing Show, recorded at the AdvaMed conference, host Wendy Pease sits down with Dr. Yuan Li, who leads DQS's medical business in North America, to uncover the regulatory, linguistic, and cultural challenges that can derail international medical device expansion.
With nearly two decades of experience in regulatory affairs and medical device certification, Dr. Li has witnessed firsthand what happens when manufacturers prioritize market potential without fully understanding what it takes to enter that market.
The certification trap: Getting approved is only the beginning
Medical device manufacturers navigating ISO 13485, MDSAP, and the EU Medical Device Regulation (MDR) already face a complicated certification landscape.
But Dr. Li argues that companies often make a fundamental strategic mistake: they evaluate a market's revenue potential before fully investigating its regulatory requirements, hospital procurement processes, and reimbursement systems.
He's seen manufacturers discover country-specific requirements halfway through the certification process, forcing them to repeat verification or testing and absorb unnecessary costs.
His advice? Bring regulatory, R&D, manufacturing, supply chain, and marketing teams together before committing to a new market.
As Dr. Li explains:
"Certification for sure, that's almost like... a ticket, right? You need a ticket to enter the event."
But having that ticket doesn't guarantee a successful outcome.
Why your marketing team needs a seat at the regulatory table
One of the episode's most revealing discussions challenges the assumption that marketing begins once a product is ready to launch.
Dr. Li argues that marketing should be involved as early as possible in product development and international expansion planning.
Why? Because even seemingly harmless promotional language can become a regulatory problem.
Claiming your device is "the best" or "twice as better" than a competitor's isn't simply creative messaging. Such claims can require scientific substantiation and regulatory scrutiny.
And when that messaging crosses borders, the stakes become even more complicated.
When one translated word creates a compliance problem
Dr. Li recalls cases where manufacturers encountered regulatory difficulties because a translation agency selected terminology that was misunderstood or carried a different meaning in the destination market.
For medical device manufacturers, translation isn't simply about making instructions for use, product labeling, or marketing materials understandable.
It's about ensuring the language accurately communicates technical information, supports patient safety, and satisfies country-specific regulatory expectations.
The conversation also tackles a timely question: Can AI be trusted to translate regulated medical device content?
Dr. Li sees significant potential in AI-assisted translation but emphasizes the continued importance of human reviewers with both industry-specific and regional expertise.
The cultural barrier most manufacturers overlook
Perhaps the episode's most unexpected insight is Dr. Li's definition of culture.
While global marketers often think about language, customs, and consumer preferences, he points to something equally important: how healthcare systems actually operate.
A manufacturer entering China, for example, may need to navigate a government-influenced procurement and reimbursement environment. In the United States, surgeons, hospitals, insurers, and other stakeholders can influence purchasing decisions differently.
That distinction changes not only how companies approach market entry but also whom they target, how they communicate, and which messages resonate.
A device can meet every applicable regulatory requirement and still struggle commercially if its manufacturer misunderstands the local healthcare ecosystem.
In this episode, you'll learn:
- Why medical device manufacturers underestimate the true complexity of international market entry.
- How ISO 13485, MDSAP, and EU MDR fit into global certification strategies.
- Why overlooking country-specific requirements can lead to repeated testing and costly launch delays.
- How to involve marketing, regulatory, R&D, and operations earlier in the expansion process.
- Why certain advertising claims can create compliance risks.
- How a single mistranslated term can cause regulatory problems.
- Where AI translation fits into highly regulated medical device communications.
- Why local reimbursement systems and hospital procurement practices matter as much as certification.
The conversation closes on a lighter note as Dr. Li shares a Chinese greeting that literally translates to "Have you eaten?" and recounts a memorable cultural misunderstanding from his early years in the United States.
The bottom line: A successful international launch requires more than a compliant medical device. It requires the right regulatory strategy, the right market intelligence, and the right communication for every audience involved.
If you're responsible for medical device regulatory affairs, international expansion, product marketing, or localization, this episode offers practical insights into the mistakes worth avoiding before your next global launch.
The Global Marketing Show is hosted by Wendy Pease, President of Rapport International, a provider of professional translation and interpreting services in more than 200 languages.
Are you a global marketing professional with stories to share?
Popular Posts
Popular industry news, interviews, technologies, and resources.
